logo
Select company
Select metric
-4996.41%EBITDA Margin
VS
Market
2
Sector
9
Industry
16
History
93
$ 6.42Close
$ 1.06 - $ 6.45 52-Week Range
Ticker Information

Ticker

ATAI

Company Name

ATAI LIFE SCIENCES NV

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATAI LIFE SCIENCES NV - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATAI - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -115.37M-4996.41%$ 2.31M
3/31/2025$ -144.77M-7770.75%$ 1.86M
12/31/2024$ -145.61M-47276.62%$ 308K
9/30/2024$ -124.54M-37625.68%$ 331K
6/30/2024$ -53.76M-14221.16%$ 378K
3/31/2024$ -29.43M-10624.91%$ 277K
12/31/2023$ -35.85M-11417.2%$ 314K
9/30/2023$ -58.12M-17400.3%$ 334K
6/30/2023$ -137.07M-50581.18%$ 271K
3/31/2023$ -141.5M-52603.35%$ 269K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATAI LIFE SCIENCES NV's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, ATAI LIFE SCIENCES NV's average EBITDA % has been -29138.34%.
  • The median EBITDA % for ATAI LIFE SCIENCES NV during this period was -29636.94%
  • ATAI LIFE SCIENCES NV reached its highest EBITDA % over the past 5 years at -842.9%.
  • The lowest EBITDA % recorded by ATAI LIFE SCIENCES NV in the same timeframe -62655.79%

ATAI LIFE SCIENCES NV's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
UPB : UPSTREAM BIO INC -3816.05%KALV : KALVISTA PHARMACEUTICALS INC -13091.58%VSTM : VERASTEM INC -7657.7%CNTB : CONNECT BIOPHARMA HOLDINGS LTD -INBX : INHIBRX BIOSCIENCES INC -10945.93%PROK : PROKIDNEY CORP -12437.38%SION : SIONNA THERAPEUTICS INC -NTRB : NUTRIBAND INC -386.12%ORMP : ORAMED PHARMACEUTICALS INC -1743.8%TRVI : TREVI THERAPEUTICS INC -

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for ATAI LIFE SCIENCES NV is calculated as follows: EBITDA [ $ -169.51M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

ATAI - EBITDA Margin, Last 5 years

-62655.79%

Minimum

Dec 31, 2022

-842.9%

Maximum

Dec 31, 2021

-29138.34%

Average

-29636.94%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.16% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.98%
max97.73%
average16.16%
median14.74%
std26.84%